Source: CureToday articles
Younger patients with lung cancer are more likely to have mutations that allow for targeted therapies, which can lead to more personalized and effective treatment.
Recent Content
- Study Reveals Safety and Effectiveness of RSV Vaccine for Older Adults
- Younger Patients With Lung Cancer Often Have Targetable Biomarkers
- First Nationwide Seroprevalence Study of HDV in the US Offers Prevalence of HDV Among HBsAg-Positive Specimens
- Insights from a Pharmacy Times Peer Exchange: Real-World Outcomes and Supportive Care
- Facing Cancer as an AYA and Navigating Fertility Preservation Choices
- What Patients Should Know About a Melanoma Diagnosis
- FDA Approved Antihemophilic factor, PEGylated-Aucl For Pediatric Patients With Hemophilia A
- Answers to Frequently Asked Questions About Prostate Cancer Risk, Treatment
- Reflecting on my Son’s Graduation as a Previvor
- FDA Grants Market Clearance to Diagnostic Blood Test for Alzheimer Disease